Literature DB >> 12479372

QSAR for anti-HIV activity of HEPT derivatives.

H Bazoui1, M Zahouily, S Boulajaaj, S Sebti, D Zakarya.   

Abstract

QSARs were derived for 103 analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT), a potent inhibitor of the HIV-1 reverse transcriptase (RT). The activity of these compounds was investigated by means of multiple linear regression (MLR) and artificial neural network (ANN) techniques. Considering the relevant descriptors obtained from the MLR, a correlation coefficient of 0.92 (n = 95) was obtained with a 4-5-1 ANN model. The contribution of each descriptor to the structure-activity relationships was evaluated. The results showed that the anti-HIV activity of HEPT derivatives was strongly dependent on hydrophobic character and also steric factors of substituents.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12479372     DOI: 10.1080/1062936021000020035

Source DB:  PubMed          Journal:  SAR QSAR Environ Res        ISSN: 1026-776X            Impact factor:   3.000


  4 in total

1.  QSAR for anti-malarial activity of 2-aziridinyl and 2,3-bis(aziridinyl)-1,4-naphthoquinonyl sulfonate and acylate derivatives.

Authors:  Mohamed Zahouily; Mohamed Lazar; Abdelhakim Elmakssoudi; Jamila Rakik; Sanaa Elaychi; A Rayadh
Journal:  J Mol Model       Date:  2005-12-09       Impact factor: 1.810

2.  A novel simple QSAR model for the prediction of anti-HIV activity using multiple linear regression analysis.

Authors:  Antreas Afantitis; Georgia Melagraki; Haralambos Sarimveis; Panayiotis A Koutentis; John Markopoulos; Olga Igglessi-Markopoulou
Journal:  Mol Divers       Date:  2006-08-01       Impact factor: 2.943

3.  Artificial neural networks: non-linear QSAR studies of HEPT derivatives as HIV-1 reverse transcriptase inhibitors.

Authors:  Latifa Douali; Didier Villemin; Abdelmajid Zyad; Driss Cherqaoui
Journal:  Mol Divers       Date:  2004       Impact factor: 2.943

4.  Comparative QSAR analysis of cyclo-oxygenase2 inhibiting drugs.

Authors:  Arumugam Mohanapriya; Dayalan Achuthan
Journal:  Bioinformation       Date:  2012-04-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.